Activation of the farnesol X receptor (FXR) promotes FAO-related gene expression in TECs; this activation mitigates the effects of cisplatin-induced AKI and reduces lipid accumulation, protecting against FAO-mediated renal damage (Xu et al., 2022). Here, NR1H4 is linked to acute kidney injury.